Correlación de la captación de 18F-FDG de la PET/TC con el Ki67 de la inmunohistoquímica en el cáncer epitelial de ovario pretratamiento / Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer

Objetivo. El Standardized uptake value (SUV) y los parámetros volumétricos volumen metabólico tumoral (MTV) y glicolisis total de la lesión (TLG) de la 18F-FDG PET/TC son útiles para determinar el pronóstico preoperatorio y postratamiento del cáncer epitelial de ovario (CEO). El Ki67 es otro marcador pronóstico en el CEO asociado con la agresividad tumoral. El objetivo fue estudiar la asociación entre los parámetros de la 18F-FDG PET/TC y el Ki67 en el CEO pretratamiento para determinar si la PET/TC puede predecir la agresividad tumoral de forma no invasiva. Material y métodos. Se realizó una PET/TC a 18 pacientes con sospecha o recién diagnóstico de CEO. Se obtuvo el SUV máximo (SUVmax), SUV medio (SUVmean) y el MTV y la TLG corporal (wbMTV y wbTLG, respectivamente), con un dintel del 30%-40% del SUVmax. Se estimó el índice de Ki67 (medio y máximo) en muestras del tejido tumoral, y se correlacionó con los parámetros de la PET. Resultados. La edad media fue 57,0 años (desviación estándar 13,6 años). Se observó una moderada correlación entre el Ki67 medio y el SUVmax (r=0.392), SUVmean 30% (r=0.437) y SUVmean 40% (r=0.443), así como entre el Ki67 máximo y el SUVmax (r=0.360), SUVmean 30% (r=0.362) y SUVmean 40% (r=0.319). La correlación fue más débil, e inversamente negativa, entre el Ki67 medio y máximo y los parámetros volumétricos de la PET. No hubo diferencias estadísticamente significativas entre las correlaciones. Conclusiones. SUVmax y SUVmean se correlacionaron moderadamente con el Ki67 mientras que los parámetros volumétricos mostraron una correlación débil. SUVmax y SUVmean podrían utilizarse para predecir la agresividad tumoral en el CEO pretratamiento (AU)

Objective. Standardised uptake value (SUV) and volumetric parameters such as metabolic tumour volume (MTV) and total lesion glycolysis (TLG) from 18F-FDG PET/CT are useful criteria for disease prognosis in pre-operative and post-treatment epithelial ovarian cancer (EOC). Ki67 is another prognostic biomarker in EOC, associated with tumour aggressiveness. The aim of this study is to evaluate the association between 18F-FDG PET/CT measurements and Ki67 in pre-treatment EOC to determine if PET/CT parameters could non-invasively predict tumour aggressiveness. Material and methods. A pre-treatment PET/CT was performed on 18 patients with suspected or newly diagnosed EOC. Maximum SUV (SUVmax), mean SUV (SUVmean), whole-body MTV (wbMTV), and whole-body TLG (wbTLG) with a threshold of 30% and 40% of the SUVmax were obtained. Furthermore, Ki67 index (mean and hotspot) was estimated in tumour tissue specimens. Immunohistochemical findings were correlated with PET parameters. Results. The mean age was 57.0 years old (standard deviation 13.6 years). A moderate correlation was observed between mean Ki67 index and SUVmax (r=0.392), SUVmean 30% (r=0.437), and SUVmean 40% (r=0.443), and also between hotspot Ki67 index and SUVmax (r=0.360), SUVmean 30% (r=0.362) and SUVmean 40% (r=0.319). There was a weaker correlation, which was inversely negative, between mean and hotspot Ki67 and volumetric PET parameters. However, no statistical significant differences were found for any correlations. Conclusions. SUVmax and SUVmean were moderately correlated with Ki67 index, whereas volumetric PET parameters overall, showed a weaker correlation. Thus, SUVmax and SUVmean could be used to assess tumour aggressiveness in pre-treatment EOC (AU)

Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer. / Correlación de la captación de 18F-FDG de la PET/TC con el Ki67 de la inmunohistoquímica en el cáncer epitelial de ovario pretratamiento.

OBJECTIVE: Standardised uptake value (SUV) and volumetric parameters such as metabolic tumour volume (MTV) and total lesion glycolysis (TLG) from 18F-FDG PET/CT are useful criteria for disease prognosis in pre-operative and post-treatment epithelial ovarian cancer (EOC). Ki67 is another prognostic biomarker in EOC, associated with tumour aggressiveness. The aim of this study is to evaluate the association between 18F-FDG PET/CT measurements and Ki67 in pre-treatment EOC to determine if PET/CT parameters could non-invasively predict tumour aggressiveness. MATERIAL AND METHODS: A pre-treatment PET/CT was performed on 18 patients with suspected or newly diagnosed EOC. Maximum SUV (SUVmax), mean SUV (SUVmean), whole-body MTV (wbMTV), and whole-body TLG (wbTLG) with a threshold of 30% and 40% of the SUVmax were obtained. Furthermore, Ki67 index (mean and hotspot) was estimated in tumour tissue specimens. Immunohistochemical findings were correlated with PET parameters. RESULTS: The mean age was 57.0 years old (standard deviation 13.6 years). A moderate correlation was observed between mean Ki67 index and SUVmax (r=0.392), SUVmean 30% (r=0.437), and SUVmean 40% (r=0.443), and also between hotspot Ki67 index and SUVmax (r=0.360), SUVmean 30% (r=0.362) and SUVmean 40% (r=0.319). There was a weaker correlation, which was inversely negative, between mean and hotspot Ki67 and volumetric PET parameters. However, no statistical significant differences were found for any correlations. CONCLUSIONS: SUVmax and SUVmean were moderately correlated with Ki67 index, whereas volumetric PET parameters overall, showed a weaker correlation. Thus, SUVmax and SUVmean could be used to assess tumour aggressiveness in pre-treatment EOC.

Dual time-point 18F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases / Imágenes en 2 tiempos con 18F-FDG PET/TC para evaluar la ablación por radiofrecuencia de las metástasis pulmonares

Aim. To establish the usefulness of dual time-point PET/CT imaging in determining the response to radiofrequency ablation (RFA) of solitary lung metastases from gastrointestinal cancer. Materials and methods. This prospective study included 18 cases (3 female, 15 male, mean age 71 ± 15 yrs) with solitary lung metastases from malignant digestive tract tumors candidates for RFA. PET/CT images 1 h after injection of 4.07 MBq/kg of 18F-FDG (standard images) were performed at baseline, 1 month, and 3 months after RFA. PET/CT images 2 h after injection centered in the thorax at 1 month after RFA were also performed (delayed images). A retention index (RI) of dual time-point images was calculated as follows: RI = (SUVmax delayed image − SUVmax standard image/SUVmax standard image) * 100. Pathological confirmation of residual tumor by histology of the treated lesion was considered as local recurrence. A negative imaging follow-up was considered as complete response. Results. Local recurrence was found in 6/18 lesions, and complete response in the remaining 12. The mean percentage change in SUVmax at 1 month and at 3 months showed a sensitivity and specificity for PET/CT of 50% and 33%, and 67% and 92%, respectively. The RI at 1 month after RFA showed a sensitivity and specificity of 83% and 92%, respectively. Conclusions. Dual time point PET/CT can predict the outcome at one month after RFA in lung metastases from digestive tract cancers. The RI can be used to indicate the need for further procedures to rule out persistent tumor due to incomplete RFA (AU)

Objetivo. Establecer la utilidad de las imágenes PET/TC en 2 tiempos en la determinación de la respuesta a la ablación por radiofrecuencia (RFA) de las metástasis pulmonares de tumores digestivos. Material y métodos. Estudio prospectivo con 18 casos (3 mujeres, 15 varones) y edad media de 71 ± 15 años con metástasis pulmonar única de cáncer digestivo candidato a tratamiento mediante RFA. Se realizaron imágenes PET/CT 1 h tras inyección de 4,07 MBq/Kg de 18F-FDG (imagen estándar) basal, un mes y 3 meses después de la RFA y una imagen tardía 2 h tras la inyección centrada en tórax un mes después de la RFA. Se calculó el índice de retención (RI): RI = (SUVmáx imagen tardía − SUVmáx imagen estándar/SUVmáx imagen estándar) * 100. La recurrencia local se confirmó con estudio histológico de la lesión tratada con RFA. Un resultado negativo en las pruebas de imagen durante el seguimiento se consideró como respuesta completa. Resultados. Se diagnosticó recidiva local en 6/18 lesiones y respuesta completa en 12/18. El cambio porcentual medio de SUVmáx al mes y a los 3 meses mostró una sensibilidad y especificidad para evaluar la respuesta a la RFA de 50% y 33% y 67% y 92%, respectivamente. El RI un mes posradiofrecuencia mostró una sensibilidad y especificidad del 83% y 92%. Conclusiones. Las imágenes en 2 tiempos con PET/TC un mes posradiofrecuencia pueden predecir el resultado de la RFA de las metástasis pulmonares de origen digestivo. El RI se puede utilizar para indicar la necesidad de otros procedimientos para descartar recurrencia tumoral debido a una RFA incompleta (AU)

Update on PET/CT colonography in the diagnosis of colorectal cancer / Actualización sobre la utilidad de la PET/TC colonografía en el diagnóstico del cáncer colorrectal

No disponible

Usefulness of 18F-FDG PET/CT in recurrent basal cell carcinoma: report of a case / Utilidad de la 18F-FDG PET/TC en el carcinoma basocelular recurrente: a propósito de un caso

We analyze the case of a patient with left periorbital infiltrating basal cell carcinoma treated with surgical excision in October 2010. Surgery included orbital exenteration and reconstruction using skin graft and radiotherapy. In May 2013 a MR imaging showed a mass in the left orbital fossa, suggesting a recurrence in the graft. A basal cell carcinoma recurrence with perineural invasion was confirmed in the biopsy. On 18F-FDG PET/CT performed, a hypermetabolic activity was observed in the left periorbital area with extension to surrounding sinus and bones. The use of 18F-FDG PET/CT in patients with advanced basal cell carcinoma has not been fully explored due to the rarity of this entity. This case demonstrates the usefulness of this technique to determine the extent of non-melanocytic recurrent skin tumors, and its value in the staging and treatment control, supporting the incorporation of 18F-FDG PET/CT in the management of advanced basal cell carcinoma (AU)

Analizamos el caso de un paciente con carcinoma basocelular infiltrante periorbitario izquierdo, tratado con exéresis quirúrgica en Octubre de 2010 incluyendo exanteración orbitaria, reconstrucción mediante injerto cutáneo y radioterapia. En Mayo de 2013 una RM demostró una masa en la fosa orbitaria izquierda, sugestiva de recidiva en el injerto. Un carcinoma basocelular morfeiforme, con invasión perineural fue confirmado mediante biopsia. Se realizó 18F-FDG PET/TC donde se observó actividad hipermetabólica en zona periorbitaria izquierda con infiltración de dicho espacio, senos paranasales y huesos circundantes. El uso de 18F-FDG PET/TC, en pacientes con carcinoma basocelular avanzado no ha sido explorado completamente debido a la rareza de esta entidad. Este caso demuestra la utilidad de esta técnica para detectar y establecer la extensión de tumores recurrentes de piel, no melanociticos y su valor en la estadificación y control del tratamiento, apoyando la incorporación de la 18F-FDG PET/TC en el manejo del carcinoma basocelular avanzado (AU)

Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.

AIM: To establish the usefulness of dual time-point PET/CT imaging in determining the response to radiofrequency ablation (RFA) of solitary lung metastases from gastrointestinal cancer. MATERIALS AND METHODS: This prospective study included 18 cases (3 female, 15 male, mean age 71±15 yrs) with solitary lung metastases from malignant digestive tract tumors candidates for RFA. PET/CT images 1h after injection of 4.07MBq/kg of (18)F-FDG (standard images) were performed at baseline, 1 month, and 3 months after RFA. PET/CT images 2h after injection centered in the thorax at 1 month after RFA were also performed (delayed images). A retention index (RI) of dual time-point images was calculated as follows: RI=(SUVmax delayed image-SUVmax standard image/SUVmax standard image)*100. Pathological confirmation of residual tumor by histology of the treated lesion was considered as local recurrence. A negative imaging follow-up was considered as complete response. RESULTS: Local recurrence was found in 6/18 lesions, and complete response in the remaining 12. The mean percentage change in SUVmax at 1 month and at 3 months showed a sensitivity and specificity for PET/CT of 50% and 33%, and 67% and 92%, respectively. The RI at 1 month after RFA showed a sensitivity and specificity of 83% and 92%, respectively. CONCLUSIONS: Dual time point PET/CT can predict the outcome at one month after RFA in lung metastases from digestive tract cancers. The RI can be used to indicate the need for further procedures to rule out persistent tumor due to incomplete RFA.

Usefulness of (18)F-FDG PET/CT in recurrent basal cell carcinoma: Report of a case.

We analyze the case of a patient with left periorbital infiltrating basal cell carcinoma treated with surgical excision in October 2010. Surgery included orbital exenteration and reconstruction using skin graft and radiotherapy. In May 2013 a MR imaging showed a mass in the left orbital fossa, suggesting a recurrence in the graft. A basal cell carcinoma recurrence with perineural invasion was confirmed in the biopsy. On (18)F-FDG PET/CT performed, a hypermetabolic activity was observed in the left periorbital area with extension to surrounding sinus and bones. The use of (18)F-FDG PET/CT in patients with advanced basal cell carcinoma has not been fully explored due to the rarity of this entity. This case demonstrates the usefulness of this technique to determine the extent of non-melanocytic recurrent skin tumors, and its value in the staging and treatment control, supporting the incorporation of (18)F-FDG PET/CT in the management of advanced basal cell carcinoma.

Cribado mediante angiogammagrafía previo a la realización de gammagrafía con leucocitos 99mTc-HMPAO en el diagnóstico de infección de prótesis articulares / Screening with angiographic images prior to 99mTc-HMPAO labelled leukocyte scintigraphy in the diagnosis of periprosthetic infection

Objetivo. Analizar la utilidad de la fase angiogammagráfica de la gammagrafía ósea en 3 fases como posible método de cribado en el diagnóstico de infección de prótesis de cadera y de rodilla, previa a la realización de la gammagrafía con leucocitos marcados. Material y métodos. Se analizaron prospectivamente 120 pacientes (70 mujeres y 50 hombres) con edad media de 71 ± 11 años y sospecha clínica de infección de prótesis de cadera (n = 63) o rodilla (n = 57), a los que se realizó gammagrafía ósea en 3 fases (angiogammagrafía, fase vascular y fase ósea) y gammagrafía con leucocitos marcados con 99mTc-HMPAO. El diagnóstico definitivo se realizó mediante estudio microbiológico o seguimiento clínico mínimo de 12 meses. Resultados. Se estableció el diagnóstico de infección de la prótesis articular en 18/120 pacientes: 10 pacientes con prótesis de cadera y 8 pacientes con prótesis de rodilla. La angiogammagrafía fue positiva en 15/18 pacientes infectados y en 21/102 pacientes no infectados, mostrando una sensibilidad del 83%, una especificidad del 79% y un valor predictivo negativo del 97%. La gammagrafía con leucocitos marcados mostró una sensibilidad y una especificidad del 72 y del 95%, respectivamente. Si se realizara la gammagrafía con leucocitos marcados exclusivamente a los pacientes con angiogammagrafía positiva, se reduciría un 70% de gammagrafías con leucocitos practicadas. No hubo ningún caso de infección con gammagrafía con leucocitos marcados positiva y angiogammagrafía negativa. Conclusiones. La angiogammagrafía es una buena técnica de cribado de infección de prótesis articulares de cadera y rodilla, disminuyendo significativamente el número de gammagrafías con leucocitos marcados, sin afectar la sensibilidad de la técnica (AU)

Aim. To evaluate the impact of the angioscintigrapy of the three phase bone scan as screening method to rule out infection of the hip and knee prosthesis prior to performing the 99mTc-HMPAO leukocyte scintigraphy. Material and methods. A total of 120 (70 women, 50 men; mean age 71 ± 11 years) with clinical suspicion of hip (n = 63) or knee (n = 57) infection of the prosthesis and clinical suspicion of infection were evaluated prospectively. All patients underwent three-phase bone scan (angioscintigraphy, vascular and bone phase) and 99mTc-HMPAO-labelled white blood cell scintigraphy. Final diagnosis of infection was made by microbiological documentation or clinical follow-up for at least 12 months. Results. Eighteen out of 120 patients were diagnosed of infection of hip prosthesis (n = 10) or knee prosthesis (n = 8). The angioscintigraphy was positive in 15/18 infected cases and in 21/102 of the non-infected cases with a sensitivity of 83%, specificity of 79% and negative predictive value of 97%. Sensitivity and specificity of 99mTc-HMPAO leukocyte scintigraphy were 72% and 95%, respectively. If the leukocyte labeled scintigraphies had been used exclusively for patients with positive angioscintigraphy, this would have saved up to 70% of the 99mTc-HMPAO leukocyte scintigraphies performed. There were no cases of infection with positive labeled leukocyte scintigraphy and negative angioscintigraphy. Conclusion. Angioscintigraphy (blood flow phase of bone scan) is a useful technique for screening for hip and knee joint prosthesis infection, significantly reducing the need for 99mTc-HMPAO leukocyte scintigraphy without affecting the sensitivity of the technique (AU)

Presencia de ganglios intramamarios en la linfogammagrafía prequirúrgica para localizar el ganglio centinela. Relevancia clínica / Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance

Objetivo: Entre las vías de drenaje linfático de un tumor mamario se encuentran las correspondientes a la cadena axilar (la más frecuente) y a las regiones extraaxilares. Dentro de estas últimas existen los denominados ganglios intramamarios (GIM). El objetivo de este estudio fue valorar la incidencia de GIM en nuestra casuística y estudiar la evolución de las pacientes que presentaron GIM en la linfogammagrafía. Material y métodos: Se han evaluado 38 pacientes (de un total de 1.725) que presentaron un GIM en la linfogammagrafía preoperatoria. Durante el acto quirúrgico, utilizando una sonda detectora, se procedió a su localización y exéresis. Posteriormente a su resección y meticuloso rastreo del lecho quirúrgico, se realizó linfadenectomía axilar en los casos en los que el ganglio centinela (GC) axilar fue positivo para metástasis. En aquellas pacientes con GC axilar negativo y GIM positivo (GIM+) se realizó también, con excepción de un caso, linfadenectomía axilar. Resultados: Se obtuvo el GIM en 34/38 pacientes estudiadas (89,5%), porque en 3 (8%) no se encontró tejido linfoide en el análisis anatomopatológico y en una (3%) no se detectó el GIM en la cirugía. Se localizaron 10 GIM metastásicos (26%) y los 24 casos restantes (63%) resultaron libres de metástasis. Durante el seguimiento clínico una de las pacientes con GIM+ desarrolló metástasis hepáticas. Las 33 pacientes restantes no presentaron recidiva. No disponemos del seguimiento de 3 pacientes. Conclusiones: Recomendamos realizar biopsia del GIM y del GC axilar cuando ambos se detecten mediante linfogammagrafía, y que el manejo axilar dependa únicamente del estatus del GC axilar. Según los datos de diversos autores y nuestra experiencia, parece razonable omitir la linfadenectomía axilar cuando nos encontremos ante un GIM+ sin afectación axilar asociada (AU)

Objective: The routes of lymphatic drainage from a breast cancer are the axilla (the most frequent) and the extra axillary regions. Among the latter, there are the so-called intrammamary lymph nodes (IMLN). This study has aimed to assess the incidence of IMLNs in our patients and study the evolution of these cases with IMLN in the lymphoscintigraphy. Material and methods: Thirty-eight patients (out of 1725) with IMLN in the pre-operative lymphoscin- tigraphy were assessed. During the surgical procedure, using a gamma probe, IMLNs were located and excised. After their harvesting, a meticulous surgical field scan was performed. When the axillary sentinel node was positive for metastasis, a complete axillary lymphadenectomy was performed. In those where the axillary sentinel node was negative and IMLN was positive (IMLN+), axillary lymphadenectomy was also performed, except for one case. Results: Thirty-four out of the 38 IMLNs were obtained (89.5%), because no lymphatic tissue was found in pathology analysis in three cases (8%) and in one patient (3%) IMLN was not found during surgery. Ten (26%) metastatic IMLNs were located and the remaining 24 IMLNs cases (63%) were metastasis-free. During the clinical follow-up, one patient with IMLN+ developed hepatic metastases. The remaining 33 patients did not present any recurrence. No follow-up data were available for three patients. Conclusions: IMLN and axillary sentinel node biopsy are recommended when both are depicted in preo- perative lymphoscintigraphy. The axilla treatment will only depend on the axillary sentinel node status. Based on the data from other authors and our own experience, avoiding the axillary lymphadenectomy when a metastatic IMLN without axillary involvement seems reasonable (AU)

[Screening with angiographic images prior to (99m)Tc-HMPAO labelled leukocyte scintigraphy in the diagnosis of periprosthetic infection]. / Cribado mediante angiogammagrafía previo a la realización de gammagrafía con leucocitos (99m)Tc-HMPAO en el diagnóstico de infección de prótesis articulares.

AIM: To evaluate the impact of the angioscintigrapy of the three phase bone scan as screening method to rule out infection of the hip and knee prosthesis prior to performing the (99m)Tc-HMPAO leukocyte scintigraphy. MATERIAL AND METHODS: A total of 120 (70 women, 50 men; mean age 71±11years) with clinical suspicion of hip (n=63) or knee (n=57) infection of the prosthesis and clinical suspicion of infection were evaluated prospectively. All patients underwent three-phase bone scan (angioscintigraphy, vascular and bone phase) and (99m)Tc-HMPAO-labelled white blood cell scintigraphy. Final diagnosis of infection was made by microbiological documentation or clinical follow-up for at least 12months. RESULTS: Eighteen out of 120 patients were diagnosed of infection of hip prosthesis (n=10) or knee prosthesis (n=8). The angioscintigraphy was positive in 15/18 infected cases and in 21/102 of the non-infected cases with a sensitivity of 83%, specificity of 79% and negative predictive value of 97%. Sensitivity and specificity of (99m)Tc-HMPAO leukocyte scintigraphy were 72% and 95%, respectively. If the leukocyte labeled scintigraphies had been used exclusively for patients with positive angioscintigraphy, this would have saved up to 70% of the (99m)Tc-HMPAO leukocyte scintigraphies performed. There were no cases of infection with positive labeled leukocyte scintigraphy and negative angioscintigraphy. CONCLUSION: Angioscintigraphy (blood flow phase of bone scan) is a useful technique for screening for hip and knee joint prosthesis infection, significantly reducing the need for (99m)Tc-HMPAO leukocyte scintigraphy without affecting the sensitivity of the technique.

[Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance]. / Presencia de ganglios intramamarios en la linfogammagrafía prequirúrgica para localizar el ganglio centinela. Relevancia clínica.

OBJECTIVE: The routes of lymphatic drainage from a breast cancer are the axilla (the most frequent) and the extra axillary regions. Among the latter, there are the so-called intrammamary lymph nodes (IMLN). This study has aimed to assess the incidence of IMLNs in our patients and study the evolution of these cases with IMLN in the lymphoscintigraphy. MATERIAL AND METHODS: Thirty-eight patients (out of 1725) with IMLN in the pre-operative lymphoscintigraphy were assessed. During the surgical procedure, using a gamma probe, IMLNs were located and excised. After their harvesting, a meticulous surgical field scan was performed. When the axillary sentinel node was positive for metastasis, a complete axillary lymphadenectomy was performed. In those where the axillary sentinel node was negative and IMLN was positive (IMLN+), axillary lymphadenectomy was also performed, except for one case. RESULTS: Thirty-four out of the 38 IMLNs were obtained (89.5%), because no lymphatic tissue was found in pathology analysis in three cases (8%) and in one patient (3%) IMLN was not found during surgery. Ten (26%) metastatic IMLNs were located and the remaining 24 IMLNs cases (63%) were metastasis-free. During the clinical follow-up, one patient with IMLN+ developed hepatic metastases. The remaining 33 patients did not present any recurrence. No follow-up data were available for three patients. CONCLUSIONS: IMLN and axillary sentinel node biopsy are recommended when both are depicted in preoperative lymphoscintigraphy. The axilla treatment will only depend on the axillary sentinel node status. Based on the data from other authors and our own experience, avoiding the axillary lymphadenectomy when a metastatic IMLN without axillary involvement seems reasonable.